Insights into Direct Nose to Brain Delivery: Current Status and Future Perspective

Therapeutic Nanoparticles for Drug Delivery in Cancer

Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,919 · see citing works

Micellar Nanocarriers: Pharmaceutical Perspectives

Torchilin, V. P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9132-0 · Cited by 1,910 · see citing works

Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury

Brines, M. L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N. C., Cerami, C., Itri, L. M., & Cerami, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10526 · Cited by 1,402 · see citing works

Intranasal delivery to the central nervous system: Mechanisms and experimental considerations

Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21924 · Cited by 1,239 · see citing works

A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes

Letchford, K., & Burt, H. M. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.11.009 · Cited by 1,145 · see citing works

Comparative Affinity of Duloxetine and Venlafaxine for Serotonin and Norepinephrine Transporters in vitro and in vivo, Human Serotonin Receptor Subtypes, and Other Neuronal Receptors

Bymaster, F. P. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00298-6 · Cited by 716 · see citing works

Intranasal Drug Delivery: How, Why and What For?

Pires, A., Fortuna, A., Alves, G., & Falcão, A. (2009) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3nc79 · Cited by 641 · see citing works

Effect of chitosan on epithelial permeability and structure

Dodane, V. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00030-7 · Cited by 579 · see citing works

Triptans in Migraine

Tfelt‐Hansen, P. C., de Vries, P. W., & Saxena, P. R. (2000) · Drugs · doi:10.2165/00003495-200060060-00003 · Cited by 531 · see citing works

Nanotechnological advances for the delivery of cns therapeutics.

Wong, H. L., Wu, X. Y., & Bendayan, R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.10.007 · Cited by 488 · see citing works

SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants

Stahl, S. M., Grady, M. M., Moret, C., & Briley, M. (2005) · CNS Spectrums · doi:10.1017/s1092852900019726 · Cited by 462 · see citing works

Clarke's analysis of drugs and poisons in pharmaceuticals, body fluids and postmortem material

Moffat, A. C., Osselton, M. D., Widdop, B., Galichet, L., & Clarke, E. G. C. (2004) · Pharmaceutical Press eBooks · Cited by 435 · see citing works

Intranasal nanoemulsion based brain targeting drug delivery system of risperidone

Kumar, M., Misra, A., Babbar, A. K., Mishra, A. K., Mishra, P., & Pathak, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.03.029 · Cited by 435 · see citing works

Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery

Muchow, M., Maincent, P., & Müller, R. H. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802130061 · Cited by 394 · see citing works

Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting

Fazil, M., Md, S., Haque, S., Kumar, M., Baboota, S., Sahni, J. K., & Ali, J. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.04.013 · Cited by 379 · see citing works

Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease

Wilson, B., Samanta, M. K., Santhi, K., Kumar, K. P. S., Paramakrishnan, N., & Suresh, B. (2008) · Brain Research · doi:10.1016/j.brainres.2008.01.039 · Cited by 363 · see citing works

Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration

Yang, S., Zhu, J., Yu, L., Liang, B., & Yang, C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018888927852 · Cited by 324 · see citing works

Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting

Wang, X., Chi, N., & Tang, X. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.07.005 · Cited by 307 · see citing works

Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: Pharmacodynamic, Pharmacokinetic and Scintigraphy study in mice model

Md, S., Khan, R. A., Mustafa, G., Chuttani, K., Baboota, S., Sahni, J. K., & Ali, J. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.12.007 · Cited by 307 · see citing works

Revised estimate of the prevalence of multiple sclerosis in the united states

Anderson, D. W., Ellenberg, J. H., Leventhal, C. M., Reingold, S. C., Rodriguez, M., & Silberberg, D. H. (1992) · Annals of Neurology · doi:10.1002/ana.410310317 · Cited by 305 · see citing works

Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain

Zhang, Q., Jiang, X., Jiang, W., Lü, W., Su, L., & Shi, Z. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.01.039 · Cited by 285 · see citing works

Signaling pathways activated by interferons

Platanias, L. C., & Fish, E. N. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00109-5 · Cited by 271 · see citing works

Pharmacokinetic Optimisation of Benzodiazepine Therapy for Acute Seizures: Focus on Delivery Routes

Rey, E., Tr??luyer, J.-M., & Pons, G. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936060-00003 · Cited by 265 · see citing works

Intranasal administration of interferon beta bypasses the blood–brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis

Ross, T. M., Martinez, P. M., Renner, J. C., Thorne, R. G., Hanson, L. R., & Frey, W. H. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.02.011 · Cited by 242 · see citing works

Intranasal Deferoxamine Provides Increased Brain Exposure and Significant Protection in Rat Ischemic Stroke

Hanson, L. R., Roeytenberg, A., Martinez, P. M., Coppes, V. G., Sweet, D. C., Rao, R. J., Marti, D. L., Hoekman, J., Matthews, R. B., Frey, W. H., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.149807 · Cited by 224 · see citing works

Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route

Patel, S., Chavhan, S. S., Soni, H., Babbar, A. K., Mathur, R., Mishra, A. K., & Sawant, K. K. (2010) · Journal of drug targeting · doi:10.3109/1061186x.2010.523787 · Cited by 187 · see citing works

Intranasal Mucoadhesive Microemulsions of Clonazepam: Preliminary Studies on Brain Targeting

Vyas, T. K., Babbar, A. K., Sharma, R. K., Singh, S. S., & Misra, A. R. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20480 · Cited by 186 · see citing works

Erythropoietin in the brain: can the promise to protect be fulfilled?

Maiese, K., Li, F., & Chong, Z. Z. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.09.006 · Cited by 181 · see citing works

Nasal Drug Delivery System-Factors Affecting and Applications

Jadhav, K. R., Gambhire, M., Shaikh, I. M., Kadam, V., & Pisal, S. (2007) · Current Drug Therapy · doi:10.2174/157488507779422374 · Cited by 177 · see citing works

Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man

Ghigo, E., Arvat, E., Gianotti, L., Imbimbo, B. P., Lenaerts, V., Deghenghi, R., & Camanni, F. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.3.8126144 · Cited by 163 · see citing works

Venlafaxine loaded chitosan NPs for brain targeting: Pharmacokinetic and pharmacodynamic evaluation

Haque, S., Md, S., Fazil, M., Kumar, M., Sahni, J. K., Ali, J., & Baboota, S. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.02.051 · Cited by 158 · see citing works

Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin

Ray, B., & Lahiri, D. K. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.012 · Cited by 152 · see citing works

Sumatriptan

Perry, C. M., & Markham, A. (1998) · Drugs · doi:10.2165/00003495-199855060-00020 · Cited by 149 · see citing works

Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats

Khan, S., Patil, K., Bobade, N. N., Yeole, P. G., & Gaikwad, R. V. (2009) · Journal of drug targeting · doi:10.3109/10611860903386938 · Cited by 138 · see citing works

Pharmacokinetics of 2′, 3′-dideoxyadenosine and 2′, 3′-dideoxyinosine in patients with severe human immunodeficiency virus infection

Hartman, N. R., Yarchoan, R., Pluda, J. M., Thomas, R. V., Marczyk, K. S., Broder, S. E., & Johns, D. G. (1990) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1990.86 · Cited by 133 · see citing works

Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences

Redzic, Z. B. (2011) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-8-3 · Cited by 128 · see citing works

Delayed administration of deferoxamine reduces brain damage and promotes functional recovery after transient focal cerebral ischemia in the rat

Fréret, T., Valable, S., Chazalviel, L., Saulnier, R., MacKenzie, E. T., Petit, E., Bernaudin, M., Boulouard, M., & Schumann‐Bard, P. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04699.x · Cited by 125 · see citing works

Nanoparticulate lipid dispersions for bromocriptine delivery: Characterization and in vivo study

Esposito, E., Mariani, P., Ravani, L., Contado, C., Volta, M., Bido, S., Drechsler, M., Mazzoni, S., Menegatti, E., Morari, M., et al. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.10.015 · Cited by 119 · see citing works

Profiles of methotrexate in blood and CSF following intranasal and intravenous administration to rats

Wang, F. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00341-7 · Cited by 119 · see citing works

Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by aids viruses

Al-Ghananeem, A. M., Saeed, H. M., Florence, R. L., Yokel, R. A., & Malkawi, A. H. (2009) · Journal of drug targeting · doi:10.3109/10611860903483396 · Cited by 116 · see citing works

Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan

Vyas, T. K., Babbar, A. K., Sharma, R. K., Singh, S. S., & Misra, A. R. (2006) · AAPS PharmSciTech · doi:10.1208/pt070108 · Cited by 116 · see citing works

Intranasal mucoadhesive microemulsions of zolmitriptan: Preliminary studies on brain-targeting

Vyas, T. K., Babbar, A. K., Sharma, R. K., & Misra, A. R. (2005) · Journal of drug targeting · doi:10.1080/10611860500246217 · Cited by 113 · see citing works

Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia

Yu, Y.-P., Qiu-qin, X., Zhang, Q., Zhang, W., Zhang, L., & Wei, E.-Q. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.07.008 · Cited by 110 · see citing works

Recent Advances in Medicinal Chemistry and Pharmaceutical Technology- Strategies for Drug Delivery to the Brain

Denora, N., Trapani, A., Laquintana, V., Lopedota, A. A., & Trapani, G. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609787521571 · Cited by 104 · see citing works

Micellar Nanocarriers: Potential Nose-to-Brain Delivery of Zolmitriptan as Novel Migraine Therapy

Jain, R. D., Nabar, S., Dandekar, P. P., & Patravale, V. B. (2010) · Pharmaceutical Research · doi:10.1007/s11095-009-0041-x · Cited by 97 · see citing works

Intranasal administration of nanostructured lipid carriers containing CNS acting drug: Pharmacodynamic studies and estimation in blood and brain

Alam, M. I., Baboota, S., Ahuja, A., Ali, M., Ali, J., & Sahni, J. K. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.05.014 · Cited by 89 · see citing works

Nasal Absorption of Desmopressin in Rats and Sheep. Effect of a Bioadhesive Microsphere Delivery System

Critchley, H., Davis, S. S., Farraj, N. F., & Illum, L. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03876.x · Cited by 82 · see citing works

The Effect of Growth Hormone Secretagogues and Neuropeptide Y on Hypothalamic Hormone Release from Acute Rat Hypothalamic Explants

Korbonits, M., Little, Forsling, M. L., Tringali, Costa, A. C., Navarra, Trainer, P. J., & Grossman (1999) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1999.00353.x · Cited by 78 · see citing works

Inhibitory effects of donepezil hydrochloride (E2020) on cholinesterase activity in brain and peripheral tissues of young and aged rats

Kosasa, T., Kuriya, Y., Matsui, K., & Yamanishi, Y. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00741-4 · Cited by 69 · see citing works

Bioavailable estradiol and age at onset of Alzheimer's disease in postmenopausal women with Down syndrome

Schupf, N., Winsten, S., Patel, B. N., Pang, D. I., Ferin, M., Zigman, W. B., Silverman, W. P., & Mayeux, R. P. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.07.062 · Cited by 67 · see citing works

Mechanism of action of clonazepam in myoclonus in relation to effects on GABA and 5-HT.

Jenner, P. G., Pratt, J. A., & Marsden, C. D. (1986) · PubMed · Cited by 61 · see citing works

First human studies with a high-molecular-weight iron chelator

Dragsten, P. R., Hallaway, P. E., Hanson, G. J., Berger, A. E., Bernard, B. K., & Hedlund, B. E. (2000) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(00)70021-7 · Cited by 58 · see citing works

Formulation Development of Chitosan Coated Intra Nasal Ropinirole Nanoemulsion for Better Management Option of Parkinson: An In Vitro Ex Vivo Evaluation

Mustafa, G., Baboota, S., Ahuja, A., & Ali, J. (2012) · Current Nanoscience · doi:10.2174/157341312800620331 · Cited by 56 · see citing works

Zolmitriptan Intranasal: A Review of the Pharmacokinetics and Clinical Efficacy

Goadsby, P. J., & Yates, R. (2006) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00301.x · Cited by 54 · see citing works

The triptan formulations: a critical evaluation

BIGAL, M. E., Bordini, C. A., Antoniazzi, A. L. D. L., & Speciali, J. G. (2003) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2003000200032 · Cited by 54 · see citing works

Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats

Khan, M. S., Patil, K., Yeole, P. G., & Gaikwad, R. V. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.05.0017 · Cited by 53 · see citing works

VENLAFAXINE INGESTION IS ASSOCIATED WITH RHABDOMYOLYSIS IN ADULTS: A CASE SERIES

WILSON, A. D., Howell, C., & Waring, W. S. (2007) · The Journal of Toxicological Sciences · doi:10.2131/jts.32.97 · Cited by 52 · see citing works

Future prospects of nanoparticles on brain targeted drug delivery

Chakraborty, C., Sarkar, B., Hsu, C. H., Wen, Z., Lin, C. S., & Shieh, P.-C. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9759-2 · Cited by 46 · see citing works

Formulation and Evaluation of Novel Micellar Nanocarrier for Nasal Delivery of Sumatriptan

Jain, R. D., Nabar, S., Dandekar, P. P., Hassan, P. A., Aswal, V. K., Talmon, Y., Shet, T., Borde, L. C., Ray, K., & Patravale, V. B. (2010) · Nanomedicine · doi:10.2217/nnm.10.28 · Cited by 46 · see citing works

Interactions between the dopamine agonist, bromocriptine and the efflux protein, P-glycoprotein at the blood–brain barrier in the mouse

Vautier, S., Lacomblez, L., Chacun, H., Picard, V., Gimenez, F., Farinotti, R., & Fernandez, C. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.09.009 · Cited by 45 · see citing works

The nose may help the brain: intranasal drug delivery for treating neurological diseases

Ying, W. (2007) · Future Neurology · doi:10.2217/14796708.3.1.1 · Cited by 39 · see citing works

Direct nose-to-brain transfer of a growth hormone releasing neuropeptide, hexarelin after intranasal administration to rabbits

Yu, H. M., & Kim, K. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.05.057 · Cited by 37 · see citing works

Transdermal Administration of Bromocriptine.

Değim, İ. T., Acartürk, F., Erdoğan, D., & Ünlü, N. L. (2003) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.26.501 · Cited by 34 · see citing works

A novel role for an established player: anemia drug erythropoietin for the treatment of cerebral hypoxia/ischemia

Ehrenreich, H., Timner, W., & Sirén, A. (2004) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2004.05.001 · Cited by 30 · see citing works

Protective effect of bromocriptine against BH4-induced Cath.a cell death involving up-regulation of antioxidant enzymes

Lim, J. H., Kim, S. S., Boo, D. H., No, H., Kang, B. Y., Kim, E., Hwang, O., & Choi, H. J. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2008.12.056 · Cited by 26 · see citing works

Enhanced Oral Bioavailability of DDI After Administration of 6-Cl-ddP, an Adenosine Deaminase-Activated Prodrug, to Chronically Catheterized Rats

Anderson, B. D., Morgan, M. E., & Singhal, D. (1995) · Pharmaceutical Research · doi:10.1023/a:1016299507382 · Cited by 20 · see citing works

Drug Targeting to the Brain - A Review

Jain, A., & Jain, S. (2011) · Current Nanoscience · doi:10.2174/157341311794480255 · Cited by 16 · see citing works

Nanostructured Lipid Carrier Containing CNS Acting Drug: Formulation, Optimization and Evaluation

Alam, M. I., Baboota, S., Ahuja, A., Ali, M., Ali, J., & Sahni, J. K. (2011) · Current Nanoscience · doi:10.2174/1573413711107061014 · Cited by 16 · see citing works

Fluoxetine for Cocaine Dependence in Methadone Maintenance

Balon, R. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199410000-00016 · Cited by 9 · see citing works

Buspirone in the Treatment of Separation Anxiety in an Adolescent Boy

Balon, R. (1994) · The Canadian Journal of Psychiatry · doi:10.1177/070674379403900919 · Cited by 8 · see citing works

Nanostructured lipid carriers for site-specific drug delivery

Khosa, A., Reddi, S., & Saha, R. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.055 · Cited by 622 · see citing works

Alzheimer's Disease: Treatment Strategies and Their Limitations.

Passeri, E., Elkhoury, K., Morsink, M., Broersen, K., Linder, M., Tamayol, A., Malaplate, C., Yen, F. T., & Arab-Tehrany, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213954 · Cited by 592 · see citing works

Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa

Gänger, S., & Schindowski, K. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030116 · Cited by 447 · see citing works

Progress in brain targeting drug delivery system by nasal route

Khan, A. R., Liu, M., Khan, M. W., & Zhai, G. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.001 · Cited by 402 · see citing works

Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics

Bourganis, V., Kammona, O., Alexopoulos, A., & Kiparissides, C. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.05.009 · Cited by 357 · see citing works

Blood-brain barrier regulation in psychiatric disorders

Kealy, J., Greene, C., & Campbell, M. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.06.033 · Cited by 307 · see citing works

Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease

Fonseca‐Santos, B., Chorilli, M., & Gremião, M. P. D. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s87148 · Cited by 313 · see citing works

Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies

Costa, C. P., Moreira, J. N., Lobo, J. M. S., & Silva, A. C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.012 · Cited by 304 · see citing works

Stimuli-responsive In situ gelling system for nose-to-brain drug delivery

Agrawal, M., Saraf, S., Saraf, S., Dubey, S. K., Puri, A., Gupta, U. D., Kesharwani, P., Ravichandiran, V., Kumar, P., Naidu, V. G. M., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.044 · Cited by 299 · see citing works

Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases

Meredith, M. E., Salameh, T. S., & Banks, W. A. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9719-7 · Cited by 225 · see citing works

Targeted drug delivery to the brain via intranasal nanoemulsion: Available proof of concept and existing challenges

Chatterjee, B., Gorain, B., Mohananaidu, K., Sengupta, P., Mandal, U. K., & Choudhury, H. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.05.032 · Cited by 216 · see citing works

Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting

Selvaraj, K., Kuppusamy, G., & Karri, V. V. S. R. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1420073 · Cited by 211 · see citing works

Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier

Lee, D., & Minko, T. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122049 · Cited by 219 · see citing works

Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis

Costa, C. P., Moreira, J. N., Amaral, M. H., Lobo, J. M. S., & Silva, A. C. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.049 · Cited by 210 · see citing works

Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood–brain barrier (BBB) to manage neurological disorders

Correia, A. D. A., Monteiro, A. R., Silva, R., Moreira, J. N., Lobo, J. M. S., & Silva, A. C. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114485 · Cited by 208 · see citing works

Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery

Battaglia, L., Panciani, P., Muntoni, E., Capucchio, M., Biasibetti, E., Bonis, P. D., Mioletti, S., Fontanella, M., & Swaminathan, S. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1429401 · Cited by 185 · see citing works

Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson’s disease by reducing oxidative stress

Pangeni, R., Sharma, S., Mustafa, G., Ali, J., & Baboota, S. (2014) · Nanotechnology · doi:10.1088/0957-4484/25/48/485102 · Cited by 192 · see citing works

Olfactory deposition of inhaled nanoparticles in humans

Garcia, G. J. M., Schroeter, J. D., & Kimbell, J. S. (2015) · Inhalation Toxicology · doi:10.3109/08958378.2015.1066904 · Cited by 191 · see citing works

Electronic nose: a non-invasive technology for breath analysis of diabetes and lung cancer patients

Behera, B., Joshi, R., Anil Vishnu, G. K., Bhalerao, S., & Pandya, H. J. (2019) · Journal of Breath Research · doi:10.1088/1752-7163/aafc77 · Cited by 179 · see citing works

Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment

Andrade, S., Ramalho, M. J., Pereira, M. D. C., & Loureiro, J. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01261 · Cited by 173 · see citing works

Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders

Bahadur, S., Pardhi, D. M., Rautio, J., Rosenholm, J. M., & Pathak, K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121230 · Cited by 172 · see citing works

Nose to brain drug delivery - A promising strategy for active components from herbal medicine for treating cerebral ischemia reperfusion

Long, Y., Yang, Q., Yan, X., Zhang, Y., Wan, J., Liu, S., Li, N., & Peng, W. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104795 · Cited by 157 · see citing works

Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery

Alex, A. T., Joseph, A., Shavi, G. V., Rao, J. V., & Udupa, N. (2014) · Drug Delivery · doi:10.3109/10717544.2014.948643 · Cited by 146 · see citing works

Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport

Gandhi, S. J., Shastri, D. H., Shah, J., Nair, A. B., & Jacob, S. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040481 · Cited by 146 · see citing works

Cubosomes as an emerging platform for drug delivery: a review of the state of the art

Abourehab, M. A. S., Ansari, M. J., Singh, A., Hassan, A., Abdelgawad, M. A., Shrivastav, P., Abualsoud, B. M., Amaral, L. S., & Pramanik, S. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00031h · Cited by 143 · see citing works

Chitosan as a suitable nanocarrier material for anti-Alzheimer drug delivery

Sarvaiya, J., & Agrawal, Y. K. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.08.052 · Cited by 140 · see citing works

Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery

Bruinsmann, F. A., Pigana, S., Aguirre, T. A. S., Souto, G. D., Pereira, G. G., Bianchera, A., Fasiolo, L. T., Colombo, G., Marques, M. D. S., Pohlmann, A. R., et al. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020086 · Cited by 140 · see citing works

Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders

Md, S., Bhattamisra, S. K., Zeeshan, F., Shahzad, N., Mujtaba, M. A., Meka, V. S., Radhakrishnan, A. K., Kesharwani, P., Baboota, S., & Ali, J. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.09.022 · Cited by 138 · see citing works

In Situ-Based Gels for Nose to Brain Delivery for the Treatment of Neurological Diseases

Aderibigbe, B. A. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10020040 · Cited by 133 · see citing works

Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion

Abdou, E. M., Kandil, S. M., & Miniawy, H. M. F. E. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.030 · Cited by 124 · see citing works

Development of risperidone liposomes for brain targeting through intranasal route

Narayan, R., Singh, M., Ranjan, O. P., Nayak, Y., Garg, S., Shavi, G. V., & Nayak, U. Y. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.08.033 · Cited by 118 · see citing works

Brain targeted nanoparticulate drug delivery system of rasagiline via intranasal route

Mittal, D., Md, S., Hasan, Q., Fazil, M., Ali, A., Baboota, S., & Ali, J. (2014) · Drug Delivery · doi:10.3109/10717544.2014.907372 · Cited by 117 · see citing works

Research progress in brain-targeted nasal drug delivery

Huang, Q., Chen, X., Yu, S., Gong, G., & Shu, H. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1341295 · Cited by 114 · see citing works

Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route

Shah, B., Khunt, D., Misra, M., & Padh, H. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.04.076 · Cited by 112 · see citing works

Optimization of Nanostructured Lipid Carriers of Lurasidone Hydrochloride Using Box-Behnken Design for Brain Targeting: In Vitro and In Vivo Studies

Jazuli, I., Annu, Nabi, B., Moolakkadath, T., Alam, T., Baboota, S., & Ali, J. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.05.001 · Cited by 111 · see citing works

Engineered commensals for targeted nose-to-brain drug delivery

Shen, H., Aggarwal, N., Cui, B., Foo, G. W., He, Y., Srivastava, S. K., Li, S., Seah, M. Z. X., Wun, K. S., Ling, H., et al. (2025) · Cell · doi:10.1016/j.cell.2025.01.017 · Cited by 113 · see citing works

Recent progress in nanocarriers for direct nose to brain drug delivery

Emad, N. A., Ahmed, B., Alhalmi, A., Alzobaidi, N., & Al-Kubati, S. S. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102642 · Cited by 109 · see citing works

Memantine nanoemulsion: a new approach to treat Alzheimer’s disease

Kaur, A., Nigam, K., Srivastava, S., Tyagi, A. K., & Dang, S. (2020) · Journal of Microencapsulation · doi:10.1080/02652048.2020.1756971 · Cited by 106 · see citing works

Toxicology Evaluation of Drugs Administered via Uncommon Routes: Intranasal, Intraocular, Intrathecal/Intraspinal, and Intra-Articular

Emami, A., Tepper, J., Short, B. G., Yaksh, T. L., Bendele, A. M., Ramani, T., Cisternas, A. F., Chang, J., & Mellon, R. D. (2017) · International Journal of Toxicology · doi:10.1177/1091581817741840 · Cited by 97 · see citing works

Non-Invasive Strategies for Nose-to-Brain Drug Delivery.

Ja, T., Quispe, R. C., Khan, F., & Новак (2020) · PubMed · Cited by 95 · see citing works

Rasagiline-encapsulated chitosan-coated PLGA nanoparticles targeted to the brain in the treatment of parkinson's disease

Ahmad, N. (2017) · Journal of Liquid Chromatography & Related Technologies · doi:10.1080/10826076.2017.1343735 · Cited by 95 · see citing works

Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650

Ladel, S., Schlossbauer, P., Flamm, J., Luksch, H., Mizaikoff, B., & Schindowski, K. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11080367 · Cited by 94 · see citing works

Different Methods and Formulations of Drugs and Vaccines for Nasal Administration

Tai, J., Han, M. S., Lee, D., Park, I., Lee, S. H., & Kim, T. H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14051073 · Cited by 93 · see citing works

Intranasal drug delivery for treatment of Alzheimer’s disease

Fonseca, L., Lopes, J. A., Vieira, J., Viegas, C., Oliveira, C. S., Hartmann, R. P., & Fonte, P. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00940-7 · Cited by 92 · see citing works

Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration

Shah, B. M., Khunt, D., Misra, M., & Padh, H. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.05.008 · Cited by 92 · see citing works

Brain Signaling Systems in the Type 2 Diabetes and Metabolic Syndrome: Promising Target to Treat and Prevent These Diseases

Shpakov, A. O., Derkach, K. V., & Berstein, L. M. (2015) · Future Science OA · doi:10.4155/fso.15.23 · Cited by 92 · see citing works

Biomaterials-Enhanced Intranasal Delivery of Drugs as a Direct Route for Brain Targeting

Marcello, E., & Chiono, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043390 · Cited by 88 · see citing works

Brain delivery of buspirone hydrochloride chitosan nanoparticles for the treatment of general anxiety disorder

Bari, N. K., Fazil, M., Hassan, M. Q., Haider, M. R., Gaba, B., Narang, J. K., Baboota, S., & Ali, J. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.07.041 · Cited by 83 · see citing works

Intracellular cholesterol trafficking is dependent upon NPC2 interaction with lysobisphosphatidic acid

McCauliff, L. A., Langan, A., Li, R., Ilnytska, O., Bose, D., Waghalter, M., Lai, K., Kahn, P. C., & Storch, J. (2019) · eLife · doi:10.7554/elife.50832 · Cited by 79 · see citing works

Nanoneurotherapeutics approach intended for direct nose to brain delivery

Md, S., Mustafa, G., Baboota, S., & Ali, J. (2015) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2015.1052081 · Cited by 77 · see citing works

Optimization of Curcumin Nanocrystals as Promising Strategy for Nose-to-Brain Delivery Application

Bonaccorso, A., Gigliobianco, M. R., Pellitteri, R., Santonocito, D., Carbone, C., Martino, P. D., Puglisi, G., & Musumeci, T. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12050476 · Cited by 77 · see citing works

Dihydroergotamine (DHE) – Then and Now: A Narrative Review

Silberstein, S. D., Shrewsbury, S. B., & Hoekman, J. (2019) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13700 · Cited by 76 · see citing works

A comparison study of lipid and polymeric nanoparticles in the nasal delivery of meloxicam: Formulation, characterization, and in vitro evaluation

Akel, H., Ismail, R., Katona, G., Sabir, F., Ambrus, R., & Csóka, I. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120724 · Cited by 78 · see citing works

Nose-to-brain delivery of levetiracetam after intranasal administration to mice

Gonçalves, J., Bicker, J., Gouveia, F., Liberal, J. M. T., Oliveira, R. C., Alves, G., Falcão, A. C., & Fortuna, A. C. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.04.047 · Cited by 71 · see citing works

Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery

Shringarpure, M., Gharat, S., Momin, M. M., & Omri, A. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1823965 · Cited by 70 · see citing works

Using nanotechnology to deliver biomolecules from nose to brain — peptides, proteins, monoclonal antibodies and RNA

Borrajo, M. L., & Alonso, M. J. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01086-2 · Cited by 70 · see citing works

Targeting Small Molecule Delivery to the Brain and Spinal Cord via Intranasal Administration of Rabies Virus Glycoprotein (RVG29)-Modified PLGA Nanoparticles

Chung, E. P., Cotter, J. D., Prakapenka, A. V., Cook, R. L., DiPerna, D. M., & Sirianni, R. W. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020093 · Cited by 69 · see citing works

Nose-to-brain drug delivery mediated by polymeric nanoparticles: influence of PEG surface coating

de Oliveira, E. R., dos Santos, L. C. R., Salomão, M. A., Nascimento, T. L., Oliveira, G. D. A. R., Lião, L. M., & Lima, E. M. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00816-2 · Cited by 69 · see citing works

Preconditioning mesenchymal stem cells with the mood stabilizers lithium and valproic acid enhances therapeutic efficacy in a mouse model of Huntington's disease

Linares, G. R., Chiu, C., Scheuing, L., Leng, Y., Liao, H., Maric, D., & Chuang, D. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.04.003 · Cited by 69 · see citing works

Behavioral impairments following repeated intranasal glyphosate-based herbicide administration in mice

Baier, C. J., Gallegos, C. E., Raisman‐Vozari, R., & Minetti, A. (2017) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2017.10.004 · Cited by 71 · see citing works

RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery

Hao, R., Sun, B., Yang, L., Ma, C., & Li, S. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1760960 · Cited by 67 · see citing works

Targeted delivery of intranasally administered nanoparticles-mediated neuroprotective peptide NR2B9c to brain and neuron for treatment of ischemic stroke

Li, R., Huang, Y., Chen, L., Zhou, H.-H., Zhang, M., Chang, L., Shen, H. Y., Zhou, M., Su, P., & Zhu, D. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.10.013 · Cited by 67 · see citing works

Improving the Brain Delivery of Chemotherapeutic Drugs in Childhood Brain Tumors

Triarico, S., Maurizi, P., Mastrangelo, S., Attinà, G., Capozza, M. A., & Ruggiero, A. (2019) · Cancers · doi:10.3390/cancers11060824 · Cited by 67 · see citing works

SIRT1 and stem cells: In the forefront with cardiovascular disease, neurodegeneration and cancer

Maiese, K. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i2.235 · Cited by 66 · see citing works

Nose-to-brain delivery of antipsychotics using nanotechnology: a review

Tan, M. S. A., Parekh, H. S., Pandey, P. M., Siskind, D. J., & Falconer, J. R. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1762563 · Cited by 65 · see citing works

Quantification and Brain Targeting of Eugenol-Loaded Surface Modified Nanoparticles Through Intranasal Route in the Treatment of Cerebral Ischemia

Ahmad, N., Ahmad, R., Alam, A., & Ahmad, F. J. (2018) · Drug Research · doi:10.1055/a-0596-7288 · Cited by 64 · see citing works

Clozapine loaded nanostructured lipid carriers engineered for brain targeting via nose-to-brain delivery: Optimization and in vivo pharmacokinetic studies

Patel, H., Gandhi, P. A., Chaudhari, P. S., Desai, B. V., Desai, D. T., Dedhiya, P. P., Maulvi, F. A., & Vyas, B. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102533 · Cited by 63 · see citing works

Neurodegenerative disorders management: state-of-art and prospects of nano-biotechnology

Kumar, R., Aadil, K. R., Mondal, K., Mishra, Y. K., Oupický, D., Ramakrishna, S., & Kaushik, A. K. (2021) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2021.1993126 · Cited by 64 · see citing works

Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route

Ferreira, N. N., Granja, S., Boni, F. I., Prezotti, F. G., Ferreira, L. M. B., Cury, B. S. F., Reis, R. M., Baltazar, F., & Gremião, M. P. D. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00824-2 · Cited by 61 · see citing works

Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery

Rukmangathen, R., Muzib, Y. I., & Yalavarthi, P. R. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1619759 · Cited by 59 · see citing works

Pharmacokinetics, pharmacodynamics and toxicity of Baicalin liposome on cerebral ischemia reperfusion injury rats via intranasal administration

Yan, X., Long, Y., Yang, Q., Zheng, C., Cui, M., Ci, Z., Lv, X.-M., Li, N., & Zhang, R. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146503 · Cited by 56 · see citing works

Modulation of midbrain neurocircuitry by intranasal insulin

Edwin Thanarajah, S., Iglesias, S., Kuzmanovic, B., Rigoux, L., Stephan, K. E., Brüning, J. C., & Tittgemeyer, M. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.03.050 · Cited by 55 · see citing works

Regeneration in the nervous system with erythropoietin

Maiese, K. (2015) · Frontiers in bioscience · doi:10.2741/4408 · Cited by 55 · see citing works

Brain Uptake of Neurotherapeutics after Intranasal versus Intraperitoneal Delivery in Mice.

Chauhan, M., & Chauhan, N. B. (2015) · PubMed · Cited by 55 · see citing works

Sesame Oil-Based Nanostructured Lipid Carriers of Nicergoline, Intranasal Delivery System for Brain Targeting of Synergistic Cerebrovascular Protection

Abourehab, M. A. S., Khames, A., Genedy, S., Mostafa, S., Khaleel, M. A., Omar, M. M., & Sisi, A. M. E. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040581 · Cited by 55 · see citing works

Development of a microemulsion for encapsulation and delivery of gallic acid. The role of chitosan

Mitsou, E., Pletsa, V., Sotiroudis, G. T., Panine, P., Zoumpanioti, M., & Xenakis, A. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.110974 · Cited by 54 · see citing works

Alzheimer’s Disease: An Overview of Major Hypotheses and Therapeutic Options in Nanotechnology

Agarwal, M., Alam, R., Haider, M. K., Malik, M. Z., & Kim, D.-K. (2020) · Nanomaterials · doi:10.3390/nano11010059 · Cited by 53 · see citing works

Inflammatory signaling pathways in the treatment of Alzheimer's disease with inhibitors, natural products and metabolites (Review)

Zheng, Y., Zhang, X., Zhang, R., Wang, Z., Gan, J., Gao, Q., Yang, L., Xu, P., & Jiang, X. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5314 · Cited by 52 · see citing works

Effects of Intranasal Administration of Oxytocin and Vasopressin on Social Cognition and Potential Routes and Mechanisms of Action

Yao, S., & Kendrick, K. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020323 · Cited by 52 · see citing works

Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer’s disease in intracerebroventricular streptozotocin model for brain delivery

Zameer, S., Ali, J., Vohora, D., Najmi, A. K., & Akhtar, M. (2020) · Journal of drug targeting · doi:10.1080/1061186x.2020.1817041 · Cited by 51 · see citing works

Urban airborne PM2.5-activated microglia mediate neurotoxicity through glutaminase-containing extracellular vesicles in olfactory bulb

Chen, X., Guo, J., Huang, Y., Liu, S., Huang, Y., Zhang, Z., Zhang, F., Lu, Z., Li, F., Zheng, J., et al. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.114716 · Cited by 49 · see citing works

Development of Imatinib Mesylate-Loaded Liposomes for Nose to Brain Delivery: In Vitro and In Vivo Evaluation

Saka, R., Chella, N., & Khan, W. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-021-02072-0 · Cited by 50 · see citing works

In vitro and ex vivo experimental models for evaluation of intranasal systemic drug delivery as well as direct nose‐to‐brain drug delivery

Haasbroek‐Pheiffer, A., Niekerk, S. E. V., van der Kooy, F., Cloete, T. T., Steenekamp, J. H., & Hamman, J. H. (2023) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2348 · Cited by 49 · see citing works

Dry Powder Inhaler with the technical and practical obstacles, and forthcoming platform strategies

Gaikwad, S. S., Pathare, S. R., More, M. A., Waykhinde, N. A., Laddha, U. D., Salunkhe, K. S., Kshirsagar, S. J., Patil, S. S., & Ramteke, K. H. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.083 · Cited by 48 · see citing works

How does oxytocin modulate human behavior?

Yao, S., & Kendrick, K. M. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02898-1 · Cited by 55 · see citing works

Applications of the Keap1–Nrf2 system for gene and cell therapy

Kanninen, K. M., Pomeshchik, Y., Leinonen, H. M., Malm, T., Koıstınaho, J., & Levonen, A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.037 · Cited by 47 · see citing works

Formulating SLN and NLC as Innovative Drug Delivery Systems for Non-Invasive Routes of Drug Administration

Fonseca‐Santos, B., da Silva, P. B., Rigon, R. B., Sato, M. R., & Chorilli, M. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867326666190624155938 · Cited by 46 · see citing works

Nose-to-brain drug delivery for the treatment of Alzheimer’s disease: current advancements and challenges

Prabakaran, A., Agrawal, M., Dethe, M. R., Ahmed, H., Yadav, A. K., Gupta, U. D., & Alexander, A. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2029845 · Cited by 47 · see citing works

Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases

Chen, T., Fonseca, C. D., & Schönthal, A. H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091463 · Cited by 46 · see citing works

The uses of resveratrol for neurological diseases treatment and insights for nanotechnology based-drug delivery systems

Fonseca‐Santos, B., & Chorilli, M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119832 · Cited by 46 · see citing works

Nose to brain delivery of tailored clozapine nanosuspension stabilized using (+)-alpha-tocopherol polyethylene glycol 1000 succinate: Optimization and in vivo pharmacokinetic studies

Patel, H., Chaudhari, P. S., Gandhi, P. A., Desai, B. V., Desai, D. T., Dedhiya, P. P., Vyas, B., & Maulvi, F. A. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120474 · Cited by 45 · see citing works

Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients

Jin, Z., Han, Y., Zhang, D., Li, Z., Jing, Y., Hu, B., & Sun, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102070 · Cited by 44 · see citing works

Nose-to-brain drug delivery for the treatment of CNS disease: New development and strategies

Du, L., Chen, L., Liu, F., Wang, W., & Huang, H. (2023) · International review of neurobiology · doi:10.1016/bs.irn.2023.05.014 · Cited by 43 · see citing works

A review of chitosan-based nanocarriers as drug delivery systems for brain diseases: Critical challenges, outlooks and promises

Khodaverdi, K., Bakhshi, A., Mozafari, M. R., & Naghib, S. M. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134962 · Cited by 45 · see citing works

Donepezil HCl Liposomes: Development, Characterization, Cytotoxicity, and Pharmacokinetic Study

Rajput, A., & Butani, S. (2022) · AAPS PharmSciTech · doi:10.1208/s12249-022-02209-9 · Cited by 42 · see citing works

A novel strategy for glioblastoma treatment combining alpha-cyano-4-hydroxycinnamic acid with cetuximab using nanotechnology-based delivery systems

Ferreira, N. N., Granja, S., Boni, F. I., Ferreira, L. M. B., Reis, R. M., Baltazar, F., & Gremião, M. P. D. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00713-8 · Cited by 42 · see citing works

Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model

Sandbhor, P., Goda, J. S., Mohanty, B. S., Gera, P. B., Yadav, S., Chekuri, G., Chaudhari, P. R., Dutt, S., & Banerjee, R. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01220-8 · Cited by 41 · see citing works

Nose-to-brain co-delivery of drugs for glioblastoma treatment using nanostructured system

Ferreira, N. N., de Oliveira, E., Granja, S., Boni, F. I., Ferreira, L. M. B., Cury, B. S. F., dos Santos, L. C. R., Reis, R. M., Lima, E. M., Baltazar, F., et al. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120714 · Cited by 40 · see citing works

Assessment of Nasal-Brain-Targeting Efficiency of New Developed Mucoadhesive Emulsomes Encapsulating an Anti-Migraine Drug for Effective Treatment of One of the Major Psychiatric Disorders Symptoms

El-Enin, H. A. A., Mostafa, R. E., Ahmed, M. F. E., Naguib, I. A., Abdelgawad, M. A., Ghoneim, M. M., & Abdou, E. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020410 · Cited by 39 · see citing works

Iranian journal of basic medical sciences : IJBMS

(n.d.) · RWTH Publications (RWTH Aachen)

Nose-to-brain drug delivery: a short review of the available systems and their applications

Al-Hasnawi, D., & Al-Azzawi, S. (2025) · Pharmakeftiki

Nose-to-brain drug delivery: A new frontier in targeted therapeutics.

Sampath, K. S. S., & Korni, R. D. (2026) · PubMed Central · doi:10.22038/ijbms.2026.93677.20210

Applications of direct nose-to-brain drug delivery in biomedicine, biotechnology, tissue engineering, and immunology

Patil, S. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00012-6 · Cited by 3 · see citing works

Current advances in nose to brain drug delivery

Venkatesh Prasad, S., Sudheer, P., & Shetty, K. B. C. (2023) · Pharmaceutical Sciences Asia · doi:10.29090/psa.2023.03.23.477 · Cited by 5 · see citing works